|
|||||
|
|
| CBCSG10:A phase Ⅲ trail adjuvant capecitabine with standard chemotherapy for triple negative breast cancer | |
| 摘 要： | 正With the support from the National Natural Science Foundation of China,the research team led by Prof.Shao ZhiMin(邵志敏)at the Department of Breast Surgery,Fudan University,Shanghai Cancer Center and the Department of Oncology,Shanghai Medical College,Fudan University,recently reported that adjuvant capecitabine with docetaxel and cyclophosphamide plus epirubicin significantly improved DFS in |
| 本文献已被 CNKI 等数据库收录！ | |
| 点击此处可从《中国科学基金(英文版)》浏览原始摘要信息 | |
| 点击此处可从《中国科学基金(英文版)》下载免费的PDF全文 | |